⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPTI News
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
prnewswire.com
KPTI
Karyopharm to Participate at Upcoming Investor Conferences
prnewswire.com
KPTI
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Announces $30 Million Private Placement with RA Capital
prnewswire.com
KPTI